𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictors of anxiety in patients with Alzheimer's disease

✍ Scribed by Raymond L. Ownby; Dylan G. Harwood; Warren W. Barker; Ranjan Duara


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
54 KB
Volume
11
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinical predictors of aggressive behavi
✍ Niall Gormley; M. R. Rizwan; Simon Lovestone πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

## Objectives: To examine the level and clinical correlates of aggressive behaviour in alzheimer's disease (ad). ## Method: Seventy patients with probable ad were rated using validated assessment instruments including the rating scale for aggressive behaviour in the elderly (rage). ## Results:

Prevalence and correlates of anxiety in
✍ ErΓ‘n Chemerinski; Gustavo Petracca; Facundo Manes; RamΓ³n Leiguarda; Sergio E. St πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 59 KB πŸ‘ 2 views

We assessed a consecutive series of 398 patients with probable Alzheimer's disease (AD) for the presence of Generalized Anxiety Disorder (GAD) using a standardized neuropsychiatric evaluation. Five percent of patients showed GAD during the 4 weeks preceding the psychiatric evaluation. AD patients wi

Psychometric behaviour of BDI in Alzheim
✍ A. C. Wagle; L. W. Ho; S. A. Wagle; G. E. Berrios πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

The psychometric properties of the Beck Depression Inventory (BDI) in subjects with Alzheimer's disease (AD) and depression have not been fully evaluated. Item endorsement patterns may be distorted by the presence of AD. This was tested by applying the BDI to a sample of 129 subjects with probable A

DNA cytosine methylation in brain of pat
✍ Netanel G. Schwob; Josephine Nalbantoglu; Kenneth E. M. Hastings; Tom Mikkelsen; πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 399 KB πŸ‘ 1 views

## Abstract We developed a novel quantitative assay to test the hypothesis that defects in DNA cytosine methylation might be responsible for the brain chromatin abnormalities and transcriptional alterations observed in patients with Alzheimer's disease (AD). We found no significant difference in pe